NCT02991859 / 2016-003002-14: Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects |
|
|
| Completed | 2a | 56 | Europe | Fluticasone furoate (FF) Dry Powder Inhaler, Fluticasone propionate (FP) Dry Powder Inhaler, Budesonide (BUD) Turbuhaler, Placebo (ELLIPTA or DISKUS) | GlaxoSmithKline | Asthma | 12/18 | 12/18 | | |
NCT01293734: Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute Episode of Bronchial Asthma. |
|
|
| Completed | 2 | 360 | RoW | warming lung and relieving asthmatic granule and Securing origin and warming lung emplastrum, clearing lung and relieving asthmatic granule and securing origin and clearing lung emplastrum, securing origin and relieving asthmatic granule and securing origin and nourishing lung emplastrum, Theophylline Sustained-release Tablets and budesonide suspension | Liaoning University of Traditional Chinese Medicine, Shenyang Huanggu District Central Hospital, Benxi City hospital of Chinese medicine, Anshan Central Hospital | Bronchial Asthma | 01/11 | 02/11 | | |
NCT03319043: Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules. |
|
|
| Unknown status | 1/2 | 120 | RoW | Chanqin granules, Budesonide + Formoterol Fumarate, Chanqin granules analogous | Shanghai University of Traditional Chinese Medicine | Cough Variant Asthma | 12/18 | 06/19 | | |
